BMO Capital downgraded momentum stock Arena Pharma (NASDAQ: ARNA) from Outperform to Market Perform while maintaining their $10 price target.
This article: 103 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE